Genetic testing company 23andMe has filed for Chapter 11 bankruptcy.The company plans to operate during the proceedings and secure a buyer.Financial difficulties, declining customer base, and low retention were factors leading to the bankruptcy.The company's co-founder will step down, and an interim CEO will take over.